drugset / Trial / NCT01336803
Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI
NaSingle-groupOpen-labelDiagnostic
Summary
This pilot trial studies the differentiation of bone sarcomas and osteomyelitis with ferumoxytol-enhanced magnetic resonance imaging (MRI). Imaging procedures that allow doctors to more accurately differentiate between malignant bone sarcomas and osteomyelitis may help in diagnosing patients correctly and may result in more timely treatment.
Timeline
- Start
- 2011-08
- Primary completion
- 2014-07
- Completion
- 2023-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ferumoxytol | Diagnostic / imaging agent | 5 mg/kg | Intravenous |